UK brings forward winter top-up vaccines amid new Covid variant fears

Posted on:
Key Points

The UK health authorities began rolling out their winter vaccine schedule for the most medically vulnerable on Monday, brought forward from a planned early October rollout amid concerns around the new COVID variant BA.2.86...

The National Health Service (NHS) said residents of older adult care homes and people who are housebound will begin receiving their COVID and flu vaccinations from this week and other high risk groups will begin to be invited to get their top up protection ahead of winter from next week...

In the meantime, it remains vital that all those eligible come forward to receive their autumn vaccine as soon as it is offered to them, she said.. NHS England said it is rolling out its adult COVID and annual flu vaccination programmes in tandem following pressures it faced with a twindemic of flu and COVID resulting in high occupancy in hospitals and record pressure on staff last year..

With concerns arising over new COVID variants, its vital we adapt the programme and bring it forward for those most at risk, and so I strongly urge everyone eligible to come forward as soon as they can for this important protection in colder months, said Steve Russell, NHS Director of Vaccinations and Screening...

Older people and those in clinical risk groups remain at highest risk of serious illness from COVID-19...The vaccine continues to provide the best protection against serious illness and hospitalisation from COVID-19, so please make sure you get vaccinated when offered and encourage loved ones who are eligible to do the same, added Dr Mary Ramsay, Head of Immunisation at UKHSA...

You might be interested in

WHO sounds alarm as Covid-19 new variant ‘Eris’ cases rise sharply in UK

05, Aug, 23

UK is witnessing fresh spurt in the cases of Covid-19 as the new variant named Eris is spreading fast in the country

WHO classifies JN.1 as COVID-19 'variant of interest' but says it poses low risk

19, Dec, 23

The World Health Organization (WHO) designated the JN.1 coronavirus strain as a variant of interest but with a low global public health risk. It's now classified separately from the BA.2.86 lineage due to its rapid spread. Recently, a case of JN.1 coronavirus strain was detected in India.

WHO declares ‘Eris’ Covid strain a variant of interest as cases rise globally

09, Aug, 23

Health risk of EG.5, which is related to Omicron subvariant, judged to be low but may drive larger wave of infections

'Long flu': Study finds influenza symptoms can linger like long Covid

15, Dec, 23

People hospitalised with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways, much like the effe

Covid-19 JN.1: Is your vaccine effective against the new variant?

19, Dec, 23

While research on vaccine effectiveness against JN.1 is ongoing, booster doses could enhance protection by boosting the immune response, said expert.

Why It's Too Soon to Call It Covid Season

02, Oct, 23

Covid seems to spike twice a year—but unlike with flu season, not in a predictable pattern. That could be due to the virus, the environment, or the people it is infecting.

JN.1 Covid variant 'more transmissible, more infectious': Ex-ICMR expert warns of more cases in India

30, Dec, 23

Dr Soumya Swaminathan warns that the JN.1 Covid-19 variant is more transmissible and infectious than other variants. However, she assures that the public health risk is still low due to immunity from vaccines and past infections.